# Squid Liquid Embolic Agent for the Embolization of Abdominopelvic Arterial Bleeding Syndrome (SQUIDperi Study)

> **NCT04787120** · — · UNKNOWN · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 110 (estimated)

## Conditions studied

- Arterial Bleed
- Abdominal
- Embolism Arterial
- Pelvic Bleeding

## Interventions

- **DEVICE:** SQUIDperi

## Key facts

- **NCT ID:** NCT04787120
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2023-10-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04787120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04787120, "Squid Liquid Embolic Agent for the Embolization of Abdominopelvic Arterial Bleeding Syndrome (SQUIDperi Study)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04787120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*